[3H]Mianserin binding to solubilized membranes of frontal cortex. 1982

B Chan, and B K Madras

[3H]Mianserin binding sites were characterized in membranes of dog frontal cortex and solubilized with digitonin. The solubilized [3H]mianserin binding sites retained the binding characteristics of the membrane preparation. The dissociation constant (KD) for the soluble material was 2.2 nM which compared closely to that of the membrane-bound site (1.1 nM). Drug binding profiles indicated that the solubilized sites were both serotonergic and histaminergic in nature. Drugs active both H1- and S2-receptors potently displaced [3H]mianserin with Hill slopes close to 1. More selective serotonergic drugs such as LSD and spiperone competed for [3H]mianserin binding with shallow displacement curves. Of the neurotransmitters tested, serotonin was the most potent for both preparations. Because all the components of [3H]mianserin binding co-solubilize, the soluble material can be used to isolate individual sites.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008566 Membranes Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures. Membrane Tissue,Membrane,Membrane Tissues,Tissue, Membrane,Tissues, Membrane
D008803 Mianserin A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. Lerivon,Mianserin Hydrochloride,Mianserin Monohydrochloride,Org GB 94,Tolvon,Hydrochloride, Mianserin,Monohydrochloride, Mianserin
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

B Chan, and B K Madras
December 1980, European journal of pharmacology,
B Chan, and B K Madras
February 1985, Brain research,
B Chan, and B K Madras
September 1981, Naunyn-Schmiedeberg's archives of pharmacology,
B Chan, and B K Madras
November 1989, Psychiatry research,
B Chan, and B K Madras
April 1992, American journal of hypertension,
B Chan, and B K Madras
April 1984, Biochemical pharmacology,
B Chan, and B K Madras
June 1983, Japanese journal of pharmacology,
B Chan, and B K Madras
March 1982, European journal of pharmacology,
Copied contents to your clipboard!